校正:与编程细胞死亡联体1抑制剂相关的致命不良事件:系统性审查和元分析
Xuewen Wang1, Shijie Wu2, Yaying Chen1
1Department of Oncology, The 900th Hospital of the People's Liberation Army Joint Service Support Force, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, China.
Frontiers in pharmacology
|March 5, 2026
概括
本研究详细说明了对先前发表的文章数字物体标识符 (DOI) 的纠正. 校正确保了科学研究的准确引用和检索,以提高可访问性.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 科学出版 科研出版
背景情况:
- 确保科学出版物的准确性对于可靠的研究传播至关重要.
- 数字物体识别器 (DOI) 对于独特识别和链接到学术文章至关重要.
研究的目的:
- 为了纠正发表文章的数字物体标识符 (DOI) 中的错误.
- 确保研究的准确引用和检索.
主要方法:
- 发布了纠正通知,以修改该文章的DOI.
- 修正后的DOI被提供给以后的参考.
主要成果:
- 错误的DOI已被确定并纠正.
- 文章现在可以通过正确的DOI访问.
结论:
- 准确的DOI对于科学文献的完整性和可访问性至关重要.
- 这种纠正有助于对研究进行适当的引用和发现.
相关概念视频
01:31The Intrinsic Apoptotic Pathway
9.0K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
56
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
56